This article addresses the critical challenge of conformational sampling in pharmacophore modeling, a cornerstone of modern computer-aided drug discovery.
This article provides a comprehensive overview of pharmacophore-based virtual screening (PBVS) protocols specifically tailored for neurodegenerative disease (NDD) targets.
This article provides a comprehensive guide for researchers and drug development professionals on establishing a robust virtual screening protocol for natural product databases.
Pharmacophore-based virtual screening (VS) has evolved into a cornerstone strategy for efficient lead identification in drug discovery.
This article provides a comprehensive guide to pharmacophore-based virtual screening (PBVS) for kinase inhibitor discovery, a critical methodology for addressing challenges like selectivity and resistance in oncology drug development.
This article provides a detailed comparative analysis of structure-based and ligand-based pharmacophore modeling, two pivotal computational strategies in modern drug discovery.
This article provides a comprehensive overview of the core pharmacophore features—hydrogen bond acceptors, donors, and hydrophobic groups—which are fundamental to molecular recognition in drug design.
This article provides a comprehensive analysis of the real-world clinical utility of Next-Generation Sequencing (NGS) in oncology, tailored for researchers, scientists, and drug development professionals.
Next-generation sequencing (NGS) has become a cornerstone of precision oncology, yet the consistency of results across different laboratories is paramount for clinical trust and drug development.
Targeted next-generation sequencing (NGS) is a cornerstone of modern genomics research and clinical diagnostics, with hybridization capture and amplicon-based methods being the two predominant target enrichment techniques.